Gary l. Crocker

All filings by Gary l. Crocker on record concern Merrimack Pharmaceuticals Inc, in the capacity of chief executive. The record holds 22 filings, for trades running from 11 January 2022 to 10 August 2023.

Every open-market trade on record is a purchase: 22 purchases worth €336k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2023 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €15k and half below. 10 out of 22 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 14 August 2023 with an open-market purchase (€23k) in Merrimack Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.